Annual ROE
-46.62%
+103.57%+68.96%
December 31, 2023
Summary
- As of February 8, 2025, CYCN annual return on equity is -46.62%, with the most recent change of +103.57% (+68.96%) on December 31, 2023.
- During the last 3 years, CYCN annual ROE has risen by +52.35% (+52.89%).
- CYCN annual ROE is now -104.23% below its all-time high of 1103.42%, reached on December 31, 2018.
Performance
CYCN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-51.71%
-83.03%-265.10%
September 30, 2024
Summary
- As of February 8, 2025, CYCN quarterly return on equity is -51.71%, with the most recent change of -83.03% (-265.10%) on September 30, 2024.
- Over the past year, CYCN quarterly ROE has increased by +58.51% (+53.08%).
- CYCN quarterly ROE is now -103.69% below its all-time high of 1399.68%, reached on March 31, 2019.
Performance
CYCN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CYCN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.0% | +53.1% |
| 3 y3 years | +52.9% | +47.5% |
| 5 y5 years | -104.2% | +75.5% |
CYCN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.0% | -265.1% | +78.0% |
| 5 y | 5-year | at high | +83.5% | -265.1% | +78.0% |
| alltime | all time | -104.2% | +83.5% | -103.7% | +83.7% |
Cyclerion Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -51.71%(-265.1%) |
| Jun 2024 | - | 31.32%(+1710.4%) |
| Mar 2024 | - | 1.73%(-102.9%) |
| Dec 2023 | -46.62%(-69.0%) | -60.23%(-45.4%) |
| Sep 2023 | - | -110.22%(-53.1%) |
| Jun 2023 | - | -234.86%(+15.2%) |
| Mar 2023 | - | -203.94%(+27.3%) |
| Dec 2022 | -150.19%(+56.7%) | -160.15%(+23.4%) |
| Sep 2022 | - | -129.76%(+24.5%) |
| Jun 2022 | - | -104.26%(+3.9%) |
| Mar 2022 | - | -100.31%(+7.9%) |
| Dec 2021 | -95.87% | -92.96%(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -98.56%(-8.3%) |
| Jun 2021 | - | -107.47%(+0.2%) |
| Mar 2021 | - | -107.24%(+4.8%) |
| Dec 2020 | -98.97%(-64.9%) | -102.31%(+6.4%) |
| Sep 2020 | - | -96.19%(+4.5%) |
| Jun 2020 | - | -92.07%(-24.9%) |
| Mar 2020 | - | -122.54%(-12.7%) |
| Dec 2019 | -281.86%(-125.5%) | -140.43%(-33.5%) |
| Sep 2019 | - | -211.16%(-33.3%) |
| Jun 2019 | - | -316.66%(-122.6%) |
| Mar 2019 | - | 1399.68%(+26.8%) |
| Dec 2018 | 1103.42%(+0.6%) | 1103.42% |
| Dec 2017 | 1096.32% | - |
FAQ
- What is Cyclerion Therapeutics annual return on equity?
- What is the all time high annual ROE for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual ROE year-on-year change?
- What is Cyclerion Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly ROE year-on-year change?
What is Cyclerion Therapeutics annual return on equity?
The current annual ROE of CYCN is -46.62%
What is the all time high annual ROE for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual return on equity is 1103.42%
What is Cyclerion Therapeutics annual ROE year-on-year change?
Over the past year, CYCN annual return on equity has changed by +103.57% (+68.96%)
What is Cyclerion Therapeutics quarterly return on equity?
The current quarterly ROE of CYCN is -51.71%
What is the all time high quarterly ROE for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly return on equity is 1399.68%
What is Cyclerion Therapeutics quarterly ROE year-on-year change?
Over the past year, CYCN quarterly return on equity has changed by +58.51% (+53.08%)